Healing Hearts
Is Our Mission

We need your support!

The Minneapolis Heart Institute Foundation is an independent, nonprofit organization that is a leader in lifesaving cardiovascular research and education. MHIF research discovers hope for patients through new treatments and care practices to ensure the best outcomes for all kinds of heart and vascular conditions.

Heart disease is the #1 cause of death of men and women, claiming the lives of 700,000 people annually; our fathers and mothers; our friends and loved-ones.

Together, we can change that statistic with an investment in life-changing research and education. This heart month, we hope you'll make a special gift in honor of a loved one and the physicians, researchers and educators working to create a world without heart and vascular disease.

Get Involved on Social

Healing hearts is our mission, but without the support of our community, our work in lifesaving research and education just wouldn't be possible. This month, get involved by telling us a meaningful story, or sharing with us what is most important to you this month of February, as we also celebrate Heart Month with our community.

Below you’ll find a button to download and print an "I ❤️" sign to write on and take a selfie with for social media. Be sure to tag MHIF and use the #HealingHearts hashtag so we can amplify your message and help spread the word.

Click to Download

Sign Up For Impactful News

Stay up to date on MHIF news, events and the latest information on heart disease treatment and prevention.

First Name
Last Name
CAPTCHA

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.